HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Public Workshop To Gain Insight Into Profit-Motivated Adulteration

This article was originally published in The Rose Sheet

Executive Summary

FDA plans to hold a public workshop this spring to begin more intensively combating profit-motivated adulteration of regulated products

You may also be interested in...



Sharfstein Takes “Acting” Title Literally, Starting FDA Overhaul

Before his first week on the job was over, FDA Acting Commissioner Josh Sharfstein made decisive moves on two fronts, quickly stepping up regulation and taking steps toward an overhaul of the agency's internal culture

Sharfstein Takes “Acting” Title Literally, Starting FDA Overhaul

Before his first week on the job was over, FDA Acting Commissioner Josh Sharfstein made decisive moves on two fronts, quickly stepping up regulation and taking steps toward an overhaul of the agency's internal culture

Updated USP Glycerin Standard Should Prevent Product Adulteration

A revised testing protocol from U.S. Pharmacopeia should help prevent adulterated glycerin, an ingredient in toothpastes, from entering the U.S. supply chain

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016006

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel